Effectiveness and gastrointestinal tolerability during conversion and titration with once-daily OROS® hydromorphone extended release in opioid-tolerant patients with chronic low back pain

References

• United States Census BureauPreliminary annual estimates of the resident population for the United States, regions, states, and Puerto Rico: April 1, 2000 to July 1, 2010 (NST-PEST2010-01) [webpage on the Internet]2002 [updated Feb 2011]Washington, DCUnited States Census Bureau Available from: http://www.census.gov/popest/research/eval-estimates/eval-est2010.htmlAccessed October 22, 2012
   Google Scholar
• National Center for Health StatisticsHealth, United States, 2006. With Chartbook on Trends in the Health of AmericansHyattsville, MDNational Center for Health Statistics2006 DHS Publication No 2006-1232. Available from: http://www.cdc.gov/nchs/data/hus/hus06.pdfAccessed March 8, 2012
   Google Scholar
• HaanpääMLBackonjaMMBennettMIAssessment of neuropathic pain in primary careAm J Med2009122Suppl 10S13S2119801048
   PubMed Web of Science ®Google Scholar
• KhouzamRHChronic pain and its management in primary careSouth Med J2000931094695211147475
   PubMed Web of Science ®Google Scholar
• McCarbergBHPain management in primary care: strategies to mitigate opioid misuse, abuse, and diversionPostgrad Med2011123211913021474900
   PubMed Web of Science ®Google Scholar
• ChouRHuffmanLHAmerican Pain Society, American College of PhysiciansMedications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guidelineAnn Intern Med2007147750551417909211
   PubMed Web of Science ®Google Scholar
• ChouRFanciulloGJFinePGAmerican Pain Society–American Academy of Pain Medicine Opioids Guidelines PanelClinical guidelines for the use of chronic opioid therapy in chronic noncancer painJ Pain200910211313019187889
   PubMed Web of Science ®Google Scholar
• CaldwellJRAvinza – 24-h sustained-release oral morphine therapyExpert Opin Pharmacother20045246947214996642
   PubMed Web of Science ®Google Scholar
• RauckRLWhat is the case for prescribing long-acting opioids over short-acting opioids for patients with chronic pain? A critical reviewPain Pract20099646847919874536
   PubMed Web of Science ®Google Scholar
• MooreKTSt-FleurDMarriccoNCSteady-state pharmacokinetics of extended-release hydromorphone (OROS hydromorphone): a randomized study in healthy volunteersJ Opioid Manag20106535135821046932
   PubMedGoogle Scholar
• HaysHHagenNThirlwellMComparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer painCancer1994746180818167521784
   PubMed Web of Science ®Google Scholar
• BrueraESloanPMountBScottJSuarez-AlmazorMA randomized, double-blind, double-dummy, crossover trial comparing the safety and efficacy of oral sustained-release hydromorphone with immediate-release hydromorphone in patients with cancer painJ Clin Oncol1996145171317178622092
   PubMed Web of Science ®Google Scholar
• McCarbergBHNicholsonBDToddKHPalmerTPenlesLThe impact of pain on quality of life and the unmet needs of pain management: results from pain sufferers and physicians participating in an Internet surveyAm J Ther200815431232018645331
   PubMed Web of Science ®Google Scholar
• MystakidouKClarkAJFischerJLamAPappertKRicharzUTreatment of chronic pain by long-acting opioids and the effects on sleepPain Pract201111328228920854307
   PubMed Web of Science ®Google Scholar
• BrennanMJLiebermanJA3rdSleep disturbances in patients with chronic pain: effectively managing opioid analgesia to improve outcomesCurr Med Res Opin20092551045105519292602
   PubMed Web of Science ®Google Scholar
• FinePGMahajanGMcPhersonMLLong-acting opioids and short-acting opioids: appropriate use in chronic pain managementPain Med200910Suppl 2S79S8819691687
   PubMed Web of Science ®Google Scholar
• PergolizziJVTaylorRJrRaffaRBExtended-release formulations of tramadol in the treatment of chronic painExpert Opin Pharmacother201112111757176821609187
   PubMed Web of Science ®Google Scholar
• Parsells KellyJCookSFKaufmanDWAndersonTRosenbergLMitchellAAPrevalence and characteristics of opioid use in the US adult populationPain2008138350751318342447
   PubMed Web of Science ®Google Scholar
• Oramorph SR (morphine sulfate) Sustained-Release Tablets, CII [package insert]Newport, KYXanodyne Pharmaceticals, Inc2006
   Google Scholar
• MS Contin (morphine sulfate controlled-release) Tablets CII [package insert]Stamford, CTPurdue Pharma LP2009
   Google Scholar
• Kadian (morphine sulfate) Extended-Release Capsules, for oral use, CII [package insert]Morristown, NJActavis Elizabeth LLC2010
   Google Scholar
• Opana ER (oxymorphone hydrochloride) Extended-Release tablets, for oral use, CII [package insert]Chadds Ford, PAEndo Pharmaceuticals, Inc2008
   Google Scholar
• Avinza (morphine sulfate extended-release capsules) CII [package insert]Bristol, TNKing Pharmaceuticals, Inc2008
   Google Scholar
• OxyContin (oxycodone hydrochloride controlled-release) Tablets CII [package insert]Stamford, CTPurdue Pharma LP2010
   Google Scholar
• Embeda (morphine sulfate and naltrexone hydrochloride) Extended-Release Capsules, for oral use, CII [package insert]Bristol, TNKing Pharmaceuticals2009
   Google Scholar
• Exalgo (hydromorphone HCl) Extended-Release Tablets (CII) [package insert]Hazelwood, MOMallinckrodt Brand Pharmaceuticals, Inc2012
   Google Scholar
• Duragesic (fentanyl transdermal system) CII [package insert]Raritan, NJOrtho-McNeil-Janssen Pharmaceuticals, Inc2009
   Google Scholar
• Vicodin (hydrocodone bitartrate and acetaminophen tablets, USP) [package insert]North Chicago, ILAbbott Laboratories2011
   Google Scholar
• PapaleontiouMHendersonCRJrTurnerBJOutcomes associated with opioid use in the treatment of chronic noncancer pain in older adults: a systematic review and meta-analysisJ Am Geriatr Soc20105871353136920533971
   PubMed Web of Science ®Google Scholar
• FurlanADSandovalJAMailis-GagnonATunksEOpioids for chronic noncancer pain: a meta-analysis of effectiveness and side effectsCMAJ2006174111589159416717269
   PubMed Web of Science ®Google Scholar
• KalsoEEdwardsJEMooreRAMcQuayHJOpioids in chronic non-cancer pain: systematic review of efficacy and safetyPain2004112337238015561393
   PubMed Web of Science ®Google Scholar
• MurrayAHagenNAHydromorphoneJ Pain Symptom Manage2005295 SupplS57S6615907647
   PubMed Web of Science ®Google Scholar
• DroverDRAngstMSValleMInput characteristics and bioavailability after administration of immediate and a new extended-release formulation of hydromorphone in healthy volunteersAnesthesiology200297482783612357147
   PubMed Web of Science ®Google Scholar
• TurgeonJGröningRSathyanGThipphawongJRicharzUThe pharmacokinetics of a long-acting OROS hydromorphone formulationExpert Opin Drug Deliv20107113714419961358
   PubMed Web of Science ®Google Scholar
• GuptaSSathyanGProviding constant analgesia with OROS® hydromorphoneJ Pain Symptom Manage2007332 SupplS19S24
   Web of Science ®Google Scholar
• BrueraEPereiraJWatanabeSBelzileMKuehnNHansonJOpioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphineCancer19967848528578756381
   PubMed Web of Science ®Google Scholar
• KnotkovaHFinePGPortenoyRKOpioid rotation: the science and the limitations of the equianalgesic dose tableJ Pain Symptom Manage200938342643919735903
   PubMed Web of Science ®Google Scholar
• PalangioMNorthfeltDWPortenoyRKDose conversion and titration with a novel, once-daily, OROS osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant painJ Pain Symptom Manage200223535536812007754
   PubMed Web of Science ®Google Scholar
• WallaceMRauckRLMoulinDThipphawongJKhannaSTudorICOnce-daily OROS hydromorphone for the management of chronic nonmalignant pain: a dose-conversion and titration studyInt J Clin Pract200761101671167617877652
   PubMed Web of Science ®Google Scholar
• WallaceMRauckRLMoulinDThipphawongJKhannaSTudorICConversion from standard opioid therapy to once-daily oral extended-release hydromorphone in patients with chronic cancer painJ Int Med Res200836234335218380946
   PubMed Web of Science ®Google Scholar
• HaleMKhanAKutchMLiSOnce-daily OROS hydromorphone ER compared with placebo in opioid-tolerant patients with chronic low back painCurr Med Res Opin20102661505151820429852
   PubMed Web of Science ®Google Scholar
• HannaMThipphawongJ118 Study GroupA randomized, doubleblind comparison of OROS(R) hydromorphone and controlled-release morphine for the control of chronic cancer painBMC Palliat Care200871718976472
   PubMedGoogle Scholar
• BinsfeldHSzczepanskiLWaechterSRicharzUSabatowskiRA randomized study to demonstrate noninferiority of once-daily OROS® hydromorphone with twice-daily sustained-release oxycodone for moderate to severe chronic noncancer painPain Pract201010540441520384968
   PubMed Web of Science ®Google Scholar
• QuigleyCWiffenPA systematic review of hydromorphone in acute and chronic painJ Pain Symptom Manage200325216917812590032
   PubMed Web of Science ®Google Scholar
• HannaMTucaAThipphawongJAn open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS(R) hydromorphone in patients with chronic cancer painBMC Palliat Care200981419754935
   PubMedGoogle Scholar
• WallaceMSkowronskiRKhannaSTudorICThipphawongJEfficacy and safety evaluation of once-daily OROS hydromorphone in patients with chronic low back pain: a pilot open-label study (DO-127)Curr Med Res Opin200723598198917519065
   PubMed Web of Science ®Google Scholar
• WallaceMThipphawongJOpen-label study on the long-term efficacy, safety, and impact on quality of life of OROS hydromorphone ER in patients with chronic low back painPain Med201011101477148821199302
   PubMed Web of Science ®Google Scholar
• GalerBSCoyleNPasternakGWPortenoyRKIndividual variability in the response to different opioids: report of five casesPain199249187911375728
   PubMed Web of Science ®Google Scholar
• MercadanteSOpioid rotation for cancer pain: rationale and clinical aspectsCancer19998691856186610547561
   PubMed Web of Science ®Google Scholar
• Quang-CantagrelNDWallaceMSMagnusonSKOpioid substitution to improve the effectiveness of chronic noncancer pain control: a chart reviewAnesth Analg200090493393710735802
   PubMed Web of Science ®Google Scholar
• SlatkinNEOpioid switching and rotation in primary care: implementation and clinical utilityCurr Med Res Opin20092592133215019601703
   PubMed Web of Science ®Google Scholar
• FinePGPortenoyRKAd Hoc Expert Panel on Evidence Review and Guidelines for Opioid RotationEstablishing “best practices” for opioid rotation: conclusions of an expert panelJ Pain Symptom Manage200938341842519735902
   PubMed Web of Science ®Google Scholar
• WessonDRLingWThe Clinical Opiate Withdrawal Scale (COWS)J Psychoactive Drugs200335225325912924748
   PubMed Web of Science ®Google Scholar
• HandelsmanLCochraneKJAronsonMJNessRRubinsteinKJKanofPDTwo new rating scales for opiate withdrawalAm J Drug Alcohol Abuse19871332933083687892
   PubMed Web of Science ®Google Scholar
• MahlerDLForrestWHJrRelative analgesic potencies of morphine and hydromorphone in postoperative painAnesthesiology197542560260748347
   PubMed Web of Science ®Google Scholar
• FarrarJTYoungJPJrLaMoreauxLWerthJLPooleRMClinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scalePain200194214915811690728
   PubMed Web of Science ®Google Scholar
• FarrarJTBerlinJAStromBLClinically important changes in acute pain outcome measures: a validation studyJ Pain Symptom Manage200325540641112727037
   PubMed Web of Science ®Google Scholar
• CepedaMSFarrarJTBaumgartenMBostonRCarrDBStromBLSide effects of opioids during short-term administration: effect of age, gender, and raceClin Pharmacol Ther200374210211212891220
   PubMed Web of Science ®Google Scholar
• TingNDose Finding in Drug DevelopmentNew York, NYSpringer2006
   Google Scholar